Molecular Partners (MOLN) Short Interest Ratio & Short Volume $6.06 -0.06 (-0.98%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Molecular Partners Short Interest DataMolecular Partners (MOLN) has a short interest of 33,500 shares. This marks a 7.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 39,274 shares to cover all short positions.Current Short Interest33,500 sharesPrevious Short Interest31,200 sharesChange Vs. Previous Month+7.37%Dollar Volume Sold Short$165,825.00Short Interest Ratio1.4 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares36,690,000 sharesPercentage of Shares Shorted0.09%Today's Trading Volume1,434 sharesAverage Trading Volume39,274 sharesToday's Volume Vs. Average4% Short Selling Molecular Partners? Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMOLN Short Interest Over TimeMOLN Days to Cover Over TimeMOLN Percentage of Float Shorted Over Time Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Molecular Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202433,500 shares $165,825.00 +7.4%N/A1.4 $4.95 9/30/202431,200 shares $158,717.52 +4.4%N/A1.9 $5.09 9/15/202429,900 shares $156,078.00 +0.3%N/A1.7 $5.22 8/31/202429,800 shares $169,264.00 -8.9%N/A0.8 $5.68 8/15/202432,700 shares $206,886.36 -53.2%N/A0.9 $6.33 7/31/202469,900 shares $629,100.00 +6.2%N/A1.9 $9.00 Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 7/15/202465,800 shares $413,882.00 -23.8%N/A2.4 $6.29 6/30/202486,300 shares $623,949.00 -25.1%N/A3.2 $7.23 6/15/2024115,200 shares $779,904.00 +134.2%N/A4.6 $6.77 5/31/202449,200 shares $177,120.00 No ChangeN/A7.5 $3.60 5/15/202449,200 shares $182,532.00 -8.0%N/A13.7 $3.71 4/30/202453,500 shares $202,283.50 -5.1%N/A15.7 $3.78 4/15/202456,400 shares $222,780.00 +17.8%N/A18.8 $3.95 3/31/202447,900 shares $201,180.00 -2.2%N/A9.8 $4.20 3/15/202449,000 shares $194,040.00 -12.5%N/A3.7 $3.96 2/29/202456,000 shares $240,800.00 -7.6%N/A4.1 $4.30 2/15/202460,600 shares $282,093.00 +3.6%N/A4.5 $4.66 1/31/202458,500 shares $279,630.00 -13.7%N/A4.4 $4.78 1/15/202467,800 shares $323,406.00 +1,132.7%N/A4.9 $4.77 12/31/20235,500 shares $22,989.45 -11.3%N/A0.4 $4.18 12/15/20236,200 shares $26,102.00 -39.2%N/A2.4 $4.21 11/30/202310,200 shares $42,840.00 +117.0%N/A2.6 $4.20 11/15/20234,700 shares $20,774.00 -4.1%N/A1 $4.42 10/31/20234,900 shares $17,297.00 +2.1%N/A0.9 $3.53 10/15/20234,800 shares $20,884.32 -34.3%N/A1 $4.35 9/30/20237,300 shares $30,222.00 -73.1%N/A1.6 $4.14 9/15/202327,100 shares $123,576.00 +173.7%N/A6 $4.56 8/31/20239,900 shares $59,301.00 +135.7%N/A3.5 $5.99 8/15/20234,200 shares $24,822.00 +23.5%N/A2.1 $5.91 7/31/20233,400 shares $20,349.00 +21.4%N/A2.6 $5.99 7/15/20232,800 shares $18,312.00 -46.2%N/A2.3 $6.54 6/30/20235,200 shares $32,344.00 -3.7%N/A4 $6.22 6/15/20235,400 shares $35,748.00 +54.3%N/A4.2 $6.62 5/31/20233,500 shares $22,470.00 -31.4%N/A2.1 $6.42 5/15/20235,100 shares $33,762.51 -42.7%N/A3.6 $6.62 4/30/20238,900 shares $58,651.00 -60.4%N/A4.9 $6.59 4/15/202322,500 shares $146,925.00 +9.2%N/A10.2 $6.53 3/31/202320,600 shares $124,380.74 +32.1%N/A9.4 $6.04 3/15/202315,600 shares $91,416.00 +2.6%N/A6.2 $5.86 2/28/202315,200 shares $95,000.00 No ChangeN/A4.8 $6.25This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 2/15/202315,200 shares $97,584.00 -2.6%N/A4.5 $6.42 1/31/202315,600 shares $100,620.00 -1.3%N/A3 $6.45 1/15/202315,800 shares $107,484.24 +22.5%N/A2.8 $6.80 12/30/202212,900 shares $84,495.00 +10.3%N/A1.7 $6.55 12/15/202211,700 shares $80,028.00 -14.0%N/A1.4 $6.84 11/30/202213,600 shares $87,040.00 +9.7%N/A1.5 $6.40 11/15/202212,400 shares $86,056.00 -2.4%N/A1.3 $6.94 10/31/202212,700 shares $79,122.27 -7.3%N/A1.3 $6.23 10/15/202213,700 shares $83,433.00 -12.7%N/A1.5 $6.09 9/30/202215,700 shares $105,033.00 -20.7%N/A1.7 $6.69 9/15/202219,800 shares $124,938.00 -26.4%N/A1.9 $6.31 8/31/202226,900 shares $157,634.00 -9.4%N/A2 $5.86 8/15/202229,700 shares $201,663.00 -34.3%N/A1.6 $6.79 7/31/202245,200 shares $279,788.00 +5.6%N/A1.6 $6.19 7/15/202242,800 shares $270,496.00 -3.4%N/A1.4 $6.32 6/30/202244,300 shares $300,354.00 +13.3%N/A1.5 $6.78 6/15/202239,100 shares $265,489.00 +141.4%N/A1.4 $6.79 5/31/202216,200 shares $123,120.00 +76.1%N/A0.6 $7.60 5/15/20229,200 shares $63,480.00 -47.4%N/A0.4 $6.90 4/30/202217,500 shares $140,875.00 +14.4%N/A1.8 $8.05 4/15/202215,300 shares $292,230.00 -26.8%N/A1.4 $19.10 3/31/202220,900 shares $429,495.00 -54.5%N/A0.5 $20.55 3/15/202245,900 shares $941,409.00 -26.7%N/A1 $20.51 2/28/202262,600 shares $1.51 million -19.4%N/A1.3 $24.15 2/15/202277,700 shares $2.05 million -5.0%N/A1.5 $26.37 1/31/202281,800 shares $2.24 million -40.3%N/A1.4 $27.35 1/15/2022137,000 shares $4.37 million +1,081.0%N/A2.4 $31.89 12/31/202111,600 shares $222,488.00 -32.6%N/A0.4 $19.18 12/15/202117,200 shares $270,040.00 +45.8%N/A0.6 $15.70 11/30/202111,800 shares $165,318.00 -19.2%N/A0.5 $14.01 11/15/202114,600 shares $215,934.00 +78.1%N/A0.7 $14.79 10/29/20218,200 shares $152,602.00 -6.8%N/A0.4 $18.61 10/15/20218,800 shares $174,240.00 -59.5%N/A0.4 $19.80 9/30/202121,700 shares $425,537.00 +14.8%N/A0.9 $19.61 9/15/202118,900 shares $381,024.00 -18.2%N/A0.6 $20.16 8/31/202123,100 shares $484,176.00 +75.0%N/A0.3 $20.96 8/13/202113,200 shares $255,552.00 No ChangeN/A0.1 $19.36 MOLN Short Interest - Frequently Asked Questions What is Molecular Partners' current short interest? Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 33,500 shares of MOLN short. Learn More on Molecular Partners' current short interest. What is a good short interest ratio for Molecular Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 1.0. Learn More on Molecular Partners's short interest ratio. Is Molecular Partners' short interest increasing or decreasing? Molecular Partners saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 33,500 shares, an increase of 7.4% from the previous total of 31,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Molecular Partners' short interest compare to its competitors? Here is how the short interest of companies compare to Molecular Partners: Kodiak Sciences Inc. (2.94%), Adaptimmune Therapeutics plc (2.17%), Adverum Biotechnologies, Inc. (12.04%), Karyopharm Therapeutics Inc. (14.12%), Omega Therapeutics, Inc. (29.49%), BioXcel Therapeutics, Inc. (1.41%), Renalytix Plc (0.46%), REGENXBIO Inc. (10.10%), Pliant Therapeutics, Inc. (11.43%), Tyra Biosciences, Inc. (8.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Partners stock? Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Partners? A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further. How often is Molecular Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Kodiak Sciences Short Squeeze Adaptimmune Therapeutics Short Squeeze Adverum Biotechnologies Short Squeeze Karyopharm Therapeutics Short Squeeze Omega Therapeutics Short Squeeze BioXcel Therapeutics Short Squeeze Renalytix Short Squeeze REGENXBIO Short Squeeze Pliant Therapeutics Short Squeeze Tyra Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOLN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.